{"id":556,"date":"2011-12-02T15:11:15","date_gmt":"2011-12-02T15:11:15","guid":{"rendered":"http:\/\/ctcps.org\/blog\/?p=556"},"modified":"2014-12-30T14:59:22","modified_gmt":"2014-12-30T14:59:22","slug":"31-organizations-call-for-safe-drug-manufacturing-reforms-nov-29-2011","status":"publish","type":"post","link":"https:\/\/blog.ctcps.org\/?p=556","title":{"rendered":"31 Organizations Call for Safe Drug Manufacturing Reforms &#8211; Nov. 29 2011"},"content":{"rendered":"<p>CTCPS joins 30 other organizations in a call for Safe Drug Manufacturing Reforms<\/p>\n<p>Late yesterday, thirty advocacy organizations, representing seniors, labor, providers, patient safety advocates, cancer patients, and consumers joined Community Catalyst in calling for Congressional action to improve the safety of drug manufacturing. In letters to the<a title=\"http:\/\/www.prescriptionaccess.org\/docs\/signonletter-2011-11-29-SC-to-Senate.pdf\" href=\"http:\/\/www.prescriptionaccess.org\/docs\/signonletter-2011-11-29-SC-to-Senate.pdf\" target=\"_blank\"> Senate HELP <\/a>and <a title=\"http:\/\/www.prescriptionaccess.org\/docs\/signonletter-2011-11-29-SC-to-HR.pdf\" href=\"http:\/\/www.prescriptionaccess.org\/docs\/signonletter-2011-11-29-SC-to-HR.pdf\" target=\"_blank\">House Energy and Commerce<\/a> committees, groups urged Congress to make safe drug manufacturing legislation a priority by including new patient safeguards \u201cin the upcoming reauthorization of the Prescription Drug User Fee Authorization Act (PDUFA).\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>CTCPS joins 30 other organizations in a call for Safe Drug Manufacturing Reforms Late yesterday, thirty advocacy organizations, representing seniors, labor, providers, patient safety advocates, cancer patients, and consumers joined <\/p>\n<p class=\"readMore\"><a class=\"read-more\" href=\"https:\/\/blog.ctcps.org\/?p=556\">Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4,59],"tags":[10,21,25,27,40,42],"class_list":["post-556","post","type-post","status-publish","format-standard","hentry","category-showcase","category-patient-safety-activism","tag-advocacy","tag-drugs","tag-healthcare","tag-healthcarereform","tag-patientadvocacy","tag-pharmaceuticals"],"_links":{"self":[{"href":"https:\/\/blog.ctcps.org\/index.php?rest_route=\/wp\/v2\/posts\/556","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.ctcps.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.ctcps.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.ctcps.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.ctcps.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=556"}],"version-history":[{"count":5,"href":"https:\/\/blog.ctcps.org\/index.php?rest_route=\/wp\/v2\/posts\/556\/revisions"}],"predecessor-version":[{"id":1805,"href":"https:\/\/blog.ctcps.org\/index.php?rest_route=\/wp\/v2\/posts\/556\/revisions\/1805"}],"wp:attachment":[{"href":"https:\/\/blog.ctcps.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=556"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.ctcps.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=556"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.ctcps.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=556"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}